Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China · Delayed Price · Currency is CNY 6.48
+0.06 (0.93%)
Sep 14, 2026, 3:04 PM CST
SHE:000952 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 265 | 278.49 | 307.18 | 415.24 | 431.35 | 293.33 |
Cash & Short-Term Investments | 265 | 278.49 | 307.18 | 415.24 | 431.35 | 293.33 |
Cash Growth | -49.04% | -9.34% | -26.02% | -3.74% | 47.05% | -16.26% |
Accounts Receivable | 191.09 | 256.81 | 223.19 | 297.42 | 294.62 | 197.61 |
Other Receivables | 12.1 | 6.48 | 6.64 | 6.08 | - | 0.55 |
Receivables | 203.2 | 263.29 | 229.83 | 303.51 | 299.7 | 203.33 |
Inventory | 250.85 | 257.65 | 322.03 | 298.99 | 221.47 | 164.83 |
Other Current Assets | 55.86 | 45.05 | 61.78 | 66.93 | 52.97 | 47.47 |
Total Current Assets | 774.9 | 844.49 | 920.82 | 1,085 | 1,005 | 708.96 |
Property, Plant & Equipment | 1,115 | 1,172 | 1,577 | 1,637 | 1,199 | 1,069 |
Long-Term Investments | 53.46 | 54.13 | 7.28 | 35.2 | 44.13 | 39.79 |
Other Intangible Assets | 200.22 | 203.82 | 239.62 | 216.91 | 150.62 | 154.72 |
Long-Term Deferred Tax Assets | 24.06 | 24.78 | 20.73 | 15.88 | 27.73 | 24.81 |
Long-Term Deferred Charges | 4.58 | 4.81 | 9.12 | 10.15 | 0.58 | - |
Other Long-Term Assets | 5.93 | 8.34 | 18.82 | 30.13 | 42.25 | 51.43 |
Total Assets | 2,178 | 2,313 | 2,794 | 3,030 | 2,470 | 2,049 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 148.69 | 182.36 | 121.22 | 143.02 | 178.6 | 121.62 |
Accrued Expenses | 20.99 | 40.14 | 41.95 | 40.43 | 32.24 | 36.94 |
Short-Term Debt | 694.97 | 521.98 | 344.24 | 291.06 | 197.13 | 241.71 |
Current Portion of Long-Term Debt | 520.85 | 228 | 132.8 | 161.5 | 158.91 | 99.61 |
Current Portion of Leases | - | 0.72 | 1.05 | 1.59 | 1.2 | 0.84 |
Current Income Taxes Payable | 7.47 | 0.03 | 0.37 | 0.22 | 1.85 | 2.61 |
Current Unearned Revenue | 19.71 | 11.39 | 6.4 | 7.07 | 5.49 | 12.13 |
Other Current Liabilities | 63.28 | 401.7 | 279.5 | 220.97 | 78.61 | 24.82 |
Total Current Liabilities | 1,476 | 1,386 | 927.51 | 865.87 | 654.03 | 540.29 |
Long-Term Debt | 99.86 | 209.3 | 393.75 | 417.29 | 301.56 | 34.45 |
Long-Term Leases | 0.87 | 0.99 | 1.35 | 2.25 | 3.19 | 1.65 |
Long-Term Unearned Revenue | 11.33 | 12.57 | 13.3 | 15.65 | 18.12 | 21.04 |
Long-Term Deferred Tax Liabilities | 0.39 | 0.36 | 0.5 | 0.69 | 0.92 | 0.33 |
Other Long-Term Liabilities | 23.29 | 76.11 | 380.96 | 335.32 | 0.34 | 0.33 |
Total Liabilities | 1,612 | 1,686 | 1,717 | 1,637 | 978.17 | 598.09 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 344 | 346.75 | 349.86 | 353.86 | 353.97 | 344 |
Additional Paid-In Capital | 354.75 | 361.06 | 377.12 | 391.79 | 391.09 | 353.92 |
Retained Earnings | -104.17 | -46.23 | 358.27 | 653.56 | 793.8 | 764.58 |
Treasury Stock | - | -9.89 | -21.23 | -35.75 | -36.19 | - |
Comprehensive Income & Other | 3.1 | 2.08 | 0.93 | -0.01 | -0.02 | -0.03 |
Total Common Equity | 597.67 | 653.77 | 1,065 | 1,363 | 1,503 | 1,462 |
Minority Interest | -31.67 | -26.92 | 11.26 | 29 | -10.83 | -11.67 |
Shareholders' Equity | 566 | 626.85 | 1,076 | 1,392 | 1,492 | 1,451 |
Total Liabilities & Equity | 2,178 | 2,313 | 2,794 | 3,030 | 2,470 | 2,049 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,317 | 960.99 | 873.19 | 873.69 | 662 | 378.26 |
Net Cash (Debt) | -1,052 | -682.5 | -566.01 | -458.45 | -230.65 | -84.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.03 | -1.96 | -1.61 | -1.30 | -0.65 | -0.25 |
Filing Date Shares Outstanding | 346.95 | 346.75 | 349.86 | 353.86 | 353.97 | 344 |
Total Common Shares Outstanding | 346.95 | 346.75 | 349.86 | 353.86 | 353.97 | 344 |
Working Capital | -701.06 | -541.83 | -6.69 | 218.8 | 351.46 | 168.67 |
Book Value Per Share | 1.72 | 1.89 | 3.04 | 3.85 | 4.25 | 4.25 |
Tangible Book Value | 397.45 | 449.95 | 825.32 | 1,147 | 1,352 | 1,308 |
Tangible Book Value Per Share | 1.15 | 1.30 | 2.36 | 3.24 | 3.82 | 3.80 |
Buildings | - | 1,062 | 1,141 | 1,196 | 899.49 | 839.29 |
Machinery | - | 1,301 | 1,478 | 1,370 | 942.21 | 840.98 |
Construction In Progress | - | 16.41 | 33.1 | 60.96 | 258.14 | 204.47 |